WEDNESDAY, MAY 11
HALL A | |
09:30 - 11:30 | ACADEMIA - WHERE IS IT TAKING US? SCIENCE AND TECHNOLOGY - PREDICTION AND ANTICIPATION |
11:00 - 11:30 | Coffee Break |
Chairperson: Keren Primor Cohen, CEO, Ramot Tel Aviv University | |
09:30 - 09:35 | Opening Remarks: Keren Primor Cohen, CEO, Ramot Tel Aviv University |
09:35 - 09:42 | Tamar Harel Adar, PhD, VP R&D, Matricelf |
09:42 - 09:49 | Yan Ostrovski, PhD, Co-founder and CEO, Neshima Medical |
09:49 - 09:55 | Pini Tsukerman, PhD, Co-founder and CEO, > NectinTX Therapeutics |
09:55 - 10:02 | Prof. Ehud Gazit, PhD, Professor, Blavatnik Center for Drug Discovery |
10:02 - 10:09 | Ophir Herbst, CEO, Sequentify |
10:09 - 10:14 | Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University |
10:14 - 10:21 | David Gabay, Co-founder, Chairman and CEO, Madrigal Mental Care |
10:21 - 11:35 | Panel "Building a commercialization marketplace - no more "academic ivory towers"" |
10:21 - 10:36 | Moderator: Keren Primor Cohen, CEO, Ramot Tel Aviv University |
10:36 - 11:35 | Yuval Cabilly, PhD, Co-founder and Managing Partner, Israel Biotech Fund |
10:36 - 11:35 | Joel Bar-El, Founder and Executive Chairman, Unicorn Trax |
10:36 - 11:35 | Prof. Jacob (Koby) Rubinstein, PhD, VP, R&D and Chairman, T3 - Technion Technology |
10:36 - 11:35 | Aviv Zeevi, PhD, VP, Head of Division, Israel Innovation Authority |
10:36 - 11:35 | Lior Shahory, General Partner, Peregrine Ventures |
HALL A | |
12:00-14:00 | BIO CONVERGENCE - ENGINEERING AND BIOTECHNOLOGY COMBINED, EXPANDING TO OTHER VERTICALS |
Chairperson: Efi Cohen Arazi, CEO, TanoMed | |
12:00 - 12:05 | Opening Remarks: Efi Cohen Arazi, CEO, TanoMed |
12:05 - 12:10 | Dror Bin, CEO, Israel Innovation Authority |
12:10 - 12:22 | Daniel N. Weiss, MD, Medical Director, Enopace Biomedical |
12:22 - 12:34 | Aryeh Batt, CEO and Co-founder, Precise Bio |
12:34 - 12:46 | Ofri Vaisman, COO and General Manager, BlueWind Medical |
12:46 - 12:58 | Iris Alroy, PhD, CSO and CO-founder, Anima Biotech |
12:58 - 13:10 | Alon Meir, PhD, CSO, Seevix Material Sciences |
13:10 - 13:22 | Yuval Mandelbaum, CEO, Discure Technologies |
13:22 - 14:00 | Panel "Bio Convergence talent: the multidisciplinary opportunity and challenge” |
Moderator: Daphna Murvitz, Ceo and Co-founder, 8400-The Health Network | |
Tzvika Hartman, SVP Computational, Biolojic Design | |
Aryeh Batt, CEO and Co-founder, Precise Bio | |
Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University, | |
Merav Bassan, PhD, CDO, BiomX | |
14:00-15:00 | Lunch Break |
HALL B | |
09:30 - 14:00 | AI AND MACHINE LEARNING - TRANSFORMING TREATMENT, DRUG DISCOVERY AND DEVELOPMENT |
11:00 - 11:30 | Coffee Break |
Chairperson: Yair Benita, PhD, CTO, AION Labs | |
09:30 - 09:45 | Shai Shen-Orr, PhD, Co-founder and Chief Scientist, CytoReason |
09:45 - 10:00 | Micah Pearlman, CEO, Biolojic |
10:00 - 10:15 | Ranit Aharonov, PhD, CTO, Pangea Biomed |
10:15 - 10:30 | Anat Binur, PhD, Co-founder and CEO, UKKO |
10:30 - 10:45 | Noam Solomon, PhD, CEO, Immunai |
10:45 - 11:00 | Isaac Bentwich, MD, Founder and CEO, Quris Technologies |
11:30 - 11:45 | Nadav Askari, PhD, CTO, Genetika+ |
11:45 - 12:15 | James Weatherall, PhD, VP, Data Science and Artificial Intelligence, R&D, AztrtaZeneca, "Pushing the boundaries of science through Data Science and Artificial Intelligence," "ZOOM" |
12:15 - 12:45 | Eran Harary, MD, Global Head, Specialty R&D, Teva Pharmaceuticals, "The innovative productivity crisis in the pharmaceutical R&D - Challenges and Potential AI and ML Solutions" |
12:45 - 13:15 | Jason Johnson, PhD, Chief Data and Analytics Officer, SVP, Dana Farber Cancer Institute, "It's about the Data: strategies for enabling and productionizing Al and Machine learning," "ZOOM" |
13:15 - 13:45 | David Berry, MD, PhD, Founder, CEO and General Partner at Flagship Pioneering, Valo Health, "Accelerating drug discovery and development," "ZOOM" |
13:45 - 14:00 | Yair Benita, PhD, CTO, AION Labs |
14:00 - 15:00 | Lunch Break |
HALL C | |
09:30 - 14:00 | CURRENT AND FUTURE ROLE OF ROBOTICS IN THE MEDICAL FIELD |
11:00 - 11:30 | Coffee Break |
Chairperson: Dvir Cohen, CEO and President, Memic Innovative Surgery | |
09:30 - 09:35 | Opening Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery |
09:35 - 10:00 | Prof. Alexandre Mottrie, PhD, MD, CEO, Orsi Academy, "Past, present and future of surgical robotics, "ZOOM" |
10:00 - 10:25 | Gus Castello, Cognos-Lux Consulting LLC, "Building operational excellence in surgical robotics" |
10:25 - 10:50 | Michael Kasser, PhD, Director of Regulatory Sciences, Hogan Lovells, |
10:50 - 11:05 | Seong Ryong Kang, PhD, CEO, Korea-Israel industrial R&D foundation (KORIL), "ZOOM" with Hadar Zax, Program Manager at Israel Asia-Pacific Division, "Israel and S. Korea-the lighthouse program" |
11:30 - 11:45 | Michael Conditt, PhD, SVP, Strategic Marketing and Clinical Development, Memic Innovative Surgery |
11:45 - 12:00 | Tami Frenkel, PhD, Co-founder and CEO, Human Xtensions |
12:00 - 12:15 | Chen Levin, CEO, Xact Robotics |
12:15 - 12:30 | Noam Hassidov, CEO, Tamar Robotics |
12:30 - 12:45 | Gaddi Menahem, VP, Head of Intuitive Israel, Intuitive |
12:45 - 13:00 | Yosi Weitzman, Founder, COO/CTO, GM Israeli Site, Carevature Medical |
13:00 - 13:15 | Eyal Morag, MD, CMO, Microbot Medical |
13:15 - 13:30 | Lawrence Obstfeld, CEO, Image Navigation |
13:30 - 13:55 | Maurice R. Ferre, MD, Former co-founder and CEO, Mako Surgical, "Building a robotic company: lessons learned," "ZOOM" |
13:55 - 14:00 | Closing Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery |
14:00 - 15:00 | Lunch Break |
PLENARY SESSION | |
15:15 - 15:35 | Dror Bin, CEO, Israel Innovation Authority |
15:35 - 16:05 | Janneke Van Der Kamp, Head Region Europe, Novartis, "Bending the Curve of Life:how partnerships can redefine cardiovascular disease care" |
16:05 - 16:45 | Robert S. Langer, DSc, Institute Professor, MIT Department of Chemical Engineering, "ZOOM" Fireside Chat with: Amy W. Schulman, Managing Partner, Polaris Partners, "ZOOM" |
16:45 - 17:15 | John D. Halamka, MD, MS, President, Mayo Clinic Platform, "ZOOM" |